Vivos Insider Purchase Signals Mild Optimism Amid Market Decline
Insider buy at Vivos Therapeutics raises hopes but also highlights the company’s near‑term risks and uncertain earnings outlook.
3 minutes to read
VIVOS THERAPEUTICS INC
Vivos Therapeutics Insider Buys Signal Confidence Amid Volatility, May Trigger Short‑Term Rally
Insider buying sprees at Vivos Therapeutics signal confidence amid volatility: insiders bought 1.045M shares and 2.713M warrants at $1.34, hinting at a potential rebound.
3 minutes to read